MEDICUS PHARMA ANNOUNCES EXCLUSIVE DEVELOPMENT FOCUS FOR SKINJECT® IN GORLIN SYNDROME FOLLOWING COMMERCIAL, CLINICAL AND REGULATORY ASSESSMENT

Reuters · 1d ago

Please log in to view news